1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Tuberculosis Therapeutics Market
2.2. Global Tuberculosis Therapeutics Market, By Disease, 2023 (US$ Million)
2.3. Global Tuberculosis Therapeutics Market, By Therapy, 2023 (US$ Million)
2.4. Global Tuberculosis Therapeutics Market, By Route of Administration, 2023 (US$ Million)
2.5. Global Tuberculosis Therapeutics Market, By Dosage, 2023 (US$ Million)
2.6. Global Tuberculosis Therapeutics Market, By Distribution, 2023 (US$ Million)
2.7. Global Tuberculosis Therapeutics Market, By Geography, 2023 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2023

3. Tuberculosis Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Tuberculosis Therapeutics Market Vendors
3.2. Strategies Adopted by Tuberculosis Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Tuberculosis Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Tuberculosis Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Active TB
5.3.2. Latent TB

6. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. First-Line Therapy
6.3.2. Second-Line Therapy

7. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Others

8. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Tablets
8.3.2. Capsules
8.3.3. Injection
8.3.4. Others

9. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2023 Versus 2032
9.3. Market Segmentation
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy
9.3.3. Online Pharmacy


10. North America Tuberculosis Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
10.3. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
10.4. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
10.5. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
10.6. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
10.7.Tuberculosis Therapeutics Market: By Region, 2022-2032, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
10.7.1.1.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
10.7.1.1.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.1.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
10.7.1.1.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
10.7.1.2.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
10.7.1.2.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.2.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
10.7.1.2.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
10.7.1.3.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
10.7.1.3.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
10.7.1.3.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
10.7.1.3.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)

11. UK and European Union Tuberculosis Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.3. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.4. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.5. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.6. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.Tuberculosis Therapeutics Market: By Region, 2022-2032, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.1.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.1.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.1.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.1.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.2.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.2.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.2.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.2.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.3.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.3.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.3.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.3.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.4.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.4.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.4.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.4.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.1.5. France
11.7.1.5.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.5.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.5.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.5.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.5.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
11.7.1.6.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
11.7.1.6.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
11.7.1.6.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
11.7.1.6.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)

12. Asia Pacific Tuberculosis Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.3. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.4. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.5. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.6. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.Tuberculosis Therapeutics Market: By Region, 2022-2032, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.1.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.1.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.1.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.1.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.2.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.2.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.2.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.2.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.1.3. India
12.7.1.3.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.3.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.3.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.3.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.3.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.4.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.4.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.4.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.4.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.5.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.5.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.5.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.5.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
12.7.1.6.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
12.7.1.6.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
12.7.1.6.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
12.7.1.6.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)

13. Latin America Tuberculosis Therapeutics Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
13.3. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
13.4. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
13.5. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
13.6. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
13.7.Tuberculosis Therapeutics Market: By Region, 2022-2032, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
13.7.1.1.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
13.7.1.1.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.1.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
13.7.1.1.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
13.7.1.2.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
13.7.1.2.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.2.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
13.7.1.2.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
13.7.1.3.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
13.7.1.3.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
13.7.1.3.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
13.7.1.3.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)

14. Middle East and Africa Tuberculosis Therapeutics Market, 2022-2032, USD (Million)
14.1. Market Overview
14.2. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
14.3. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
14.4. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
14.5. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
14.6. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
14.7.Tuberculosis Therapeutics Market: By Region, 2022-2032, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
14.7.1.1.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
14.7.1.1.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.1.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
14.7.1.1.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
14.7.1.2.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
14.7.1.2.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.2.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
14.7.1.2.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Tuberculosis Therapeutics Market: By Disease, 2022-2032, USD (Million)
14.7.1.3.2. Tuberculosis Therapeutics Market: By Therapy, 2022-2032, USD (Million)
14.7.1.3.3. Tuberculosis Therapeutics Market: By Route of Administration, 2022-2032, USD (Million)
14.7.1.3.4. Tuberculosis Therapeutics Market: By Dosage, 2022-2032, USD (Million)
14.7.1.3.5. Tuberculosis Therapeutics Market: By Distribution, 2022-2032, USD (Million)

15. Company Profile
15.1. Sanofi
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Pfizer
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Johnson & Johnson
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Lupin Limited
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. AstraZeneca
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Eli Lilly and Company
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. Viatris Inc. (Mylan N.V.)
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Teva Pharmaceutical Industries, Ltd.
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Novartis AG
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Sun Pharmaceutical Industries Ltd.
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Other Notable Players
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives